ArticleCureus2026
Oral Mesotherapy as an Adjunctive Approach for the Management of Localized Periodontitis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontitis is a chronic inflammatory disease characterized by progressive destruction of the supporting structures of the teeth. While conventional therapies such as scaling and root planing (SRP) remain the cornerstone of treatment, their ability to restore previously lost periodontal attachment may be limited. Injectable platelet-rich fibrin (I-PRF), a second-generation autologous platelet concentrate, has emerged as a promising adjunct owing to its sustained release of growth factors that promote angiogenesis, fibroblast proliferation, and tissue repair. Oral mesotherapy, a minimally invasive technique involving targeted intratissue delivery, offers an innovative approach to administer I-PRF directly to the affected periodontal tissues. This case report describes a 52-year-old female diagnosed with localized Stage II, Grade B periodontitis currently unstable affecting the upper incisor region. Following SRP, the patient underwent two sessions of oral mesotherapy with I-PRF at intervals of one week. Comprehensive baseline laboratory investigations confirmed the systemic health and suitability of autologous preparation. Clinical parameters, including probing pocket depth (PPD), clinical attachment level (CAL), gingival and plaque indices, and bleeding on probing (BOP), were recorded at baseline and three months after treatment. Notable improvements were observed: PPD reduced from 5 mm to 2-3 mm, CAL improved, and BOP decreased to 10%. No adverse events were observed. This case demonstrates that oral mesotherapy with I-PRF was well tolerated and was associated with favorable clinical periodontal changes when used as an adjunct to conventional periodontal therapy for managing localized periodontitis. It is associated with faster wound healing and may enhance treatment outcomes beyond those of conventional modalities. Further controlled clinical studies are needed to validate and standardize this approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.